After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Viking Therapeutics Inc is $2.59B. A total of 3.82 million shares were traded on the day, compared to an average of 4.73M shares.
In the most recent transaction, Rouan Sarah Kathryn bought 1,240 shares of VKTX for 24.15 per share on Mar 31 ’25. After the transaction, the Director now owns 1,240 company shares. In a previous transaction on Jan 06 ’25, Lian Brian sold 194,490 shares at 42.75 per share. VKTX shares that President & CEO owns now total 2,366,570.
Among the insiders who sold shares, Mancini Marianna disposed of 54,215 shares on Jan 06 ’25 at a per-share price of $42.75. This resulted in the Chief Operating Officer holding 374,134 shares of VKTX after the transaction. In another insider transaction, ZANTE GREG sold 50,309 shares at $42.75 per share on Jan 06 ’25. Company shares held by the Chief Financial Officer now total 165,259.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VKTX has a high of $81.86 and a low of $18.92.
As of this writing, VKTX has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.42.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VKTX’s latest balance sheet shows that the firm has $202.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.00k in debt and $8.78M in liabilities at the time. Its Book Value Per Share was $7.89, while its Total Shareholder’s Equity was $201.88M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VKTX is Buy with a score of 4.76.
